10.44
price up icon7.63%   0.74
 
loading
Schlusskurs vom Vortag:
$9.70
Offen:
$9.82
24-Stunden-Volumen:
229.25K
Relative Volume:
1.83
Marktkapitalisierung:
$279.08M
Einnahmen:
$50.51M
Nettoeinkommen (Verlust:
$-29.63M
KGV:
-9.1107
EPS:
-1.1459
Netto-Cashflow:
-
1W Leistung:
+7.19%
1M Leistung:
-8.42%
6M Leistung:
-25.11%
1J Leistung:
+0.00%
1-Tages-Spanne:
Value
$9.82
$10.62
1-Wochen-Bereich:
Value
$8.50
$10.62
52-Wochen-Spanne:
Value
$8.50
$17.19

Carlsmed Inc Stock (CARL) Company Profile

Name
Firmenname
Carlsmed Inc
Name
Telefon
858-295-9290
Name
Adresse
1800 ASTON AVENUE, CARLSBAD
Name
Mitarbeiter
127
Name
Twitter
Name
Nächster Verdiensttermin
Name
Neueste SEC-Einreichungen
Name
CARL's Discussions on Twitter

Compare CARL vs VEEV, TEM, BTSG, HQY, WAY

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
CARL icon
CARL
Carlsmed Inc
10.44 238.98M 50.51M -29.63M 0 -1.1459
VEEV icon
VEEV
Veeva Systems Inc
159.09 24.73B 3.20B 908.91M 1.39B 5.4168
TEM icon
TEM
Tempus Ai Inc
49.53 7.70B 1.27B -245.03M -245.36M -1.4071
BTSG icon
BTSG
Brightspring Health Services Inc
46.04 8.71B 12.91B 104.80M 394.69M 0.8769
HQY icon
HQY
Healthequity Inc
81.36 6.59B 1.31B 215.20M 408.32M 2.4627
WAY icon
WAY
Waystar Holding Corp
22.43 4.12B 1.10B 112.09M 283.19M 0.6096

Carlsmed Inc Stock (CARL) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2025-08-18 Eingeleitet BTIG Research Buy
2025-08-18 Eingeleitet BofA Securities Buy
2025-08-18 Eingeleitet Goldman Buy
2025-08-18 Eingeleitet Piper Sandler Overweight
2025-08-18 Eingeleitet Truist Buy

Carlsmed Inc Aktie (CARL) Neueste Nachrichten

pulisher
Apr 14, 2026

Carlsmed Inc. to Report First Quarter 2026 Financial Results on May 5, 2026 - The Manila Times

Apr 14, 2026
pulisher
Apr 14, 2026

Top Carlsmed (CARL) Competitors 2026 - MarketBeat

Apr 14, 2026
pulisher
Apr 13, 2026

Carlsmed Showcases Personalized Spine Fusion Gains, Cervical Expansion and Medicare Tailwinds at Needham Conf - Yahoo Finance

Apr 13, 2026
pulisher
Apr 11, 2026

The Goldman Sachs Group Has Lowered Expectations for Carlsmed (NASDAQ:CARL) Stock Price - Defense World

Apr 11, 2026
pulisher
Apr 09, 2026

Carlsmed (CARL) Analyst Rating: Goldman Sachs Lowers Price Targe - GuruFocus

Apr 09, 2026
pulisher
Apr 09, 2026

Carlsmed (NASDAQ:CARL) Price Target Lowered to $17.00 at The Goldman Sachs Group - MarketBeat

Apr 09, 2026
pulisher
Apr 04, 2026

CARL.O Stock News Today | Earnings, Events & Price Alerts - Intellectia AI

Apr 04, 2026
pulisher
Apr 04, 2026

CARL.O PE Ratio & Valuation, Is CARL.O Overvalued - Intellectia AI

Apr 04, 2026
pulisher
Apr 04, 2026

CARL Technical Analysis & Stock Price Forecast - Intellectia AI

Apr 04, 2026
pulisher
Apr 04, 2026

CARL News & Events - Intellectia AI

Apr 04, 2026
pulisher
Apr 02, 2026

CARL.O Technical Analysis & Stock Price Forecast - Intellectia AI

Apr 02, 2026
pulisher
Apr 01, 2026

Carlsmed, Inc. To Participate in the 25th Annual Needham Virtual Conference - Bitget

Apr 01, 2026
pulisher
Mar 29, 2026

Carlsmed (NASDAQ:CARL) Upgraded at Zacks Research - Defense World

Mar 29, 2026
pulisher
Mar 28, 2026

Carlsmed (NASDAQ:CARL) Upgraded by Zacks Research to Hold Rating - MarketBeat

Mar 28, 2026
pulisher
Mar 24, 2026

Carlsmed, Inc. (NASDAQ:CARL) Receives Average Rating of "Hold" from Analysts - MarketBeat

Mar 24, 2026
pulisher
Mar 22, 2026

Carlsmed reports Q4, FY 2025 revenue above estimate - MSN

Mar 22, 2026
pulisher
Mar 21, 2026

Carlsmed, Inc.: Fundamental Analysis and Financial Ratings | I82 | US14280C1053 - marketscreener.com

Mar 21, 2026
pulisher
Mar 19, 2026

Carlsmed Poised for Positive Growth Trajectory - San Diego Business Journal

Mar 19, 2026
pulisher
Mar 19, 2026

Stryker, THINK Surgical and Carlsmed Named Winners of 2026 OMTEC® Excellence Awards - The Providence Journal

Mar 19, 2026
pulisher
Mar 16, 2026

Carlsmed joins Russell 2000 Index following Q3 IPO - MSN

Mar 16, 2026
pulisher
Mar 15, 2026

Head-To-Head Comparison: Carlsmed (CARL) vs. Its Rivals - Defense World

Mar 15, 2026
pulisher
Mar 13, 2026

Comparing Carlsmed (CARL) & The Competition - Defense World

Mar 13, 2026
pulisher
Mar 13, 2026

Head to Head Review: Carlsmed (CARL) and The Competition - Defense World

Mar 13, 2026
pulisher
Mar 10, 2026

Carlsmed Earnings Call Highlights Rapid Growth, Rising Costs - TipRanks

Mar 10, 2026
pulisher
Mar 10, 2026

Carlsmed Stock Down 6% Since IPO But Goldman Bullish And Predicts 35% Upside Potential — Retail Traders Stay Bearish - MSN

Mar 10, 2026
pulisher
Mar 10, 2026

Carlsmed (CARL) versus The Competition Head to Head Analysis - Defense World

Mar 10, 2026
pulisher
Mar 09, 2026

Carlsmed unveils custom cervical plating tech - MSN

Mar 09, 2026
pulisher
Mar 09, 2026

Carlsmed (CARL) vs. Its Peers Financial Survey - Defense World

Mar 09, 2026
pulisher
Mar 09, 2026

Carlsmed Unveils Personalized Spine Platform, Targets $70M-$75.5M 2025 Revenue at Conference - Defense World

Mar 09, 2026
pulisher
Mar 07, 2026

Contrasting Carlsmed (CARL) & Its Peers - Defense World

Mar 07, 2026
pulisher
Mar 07, 2026

Carlsmed (CARL) vs. Its Competitors Head-To-Head Contrast - Defense World

Mar 07, 2026
pulisher
Mar 07, 2026

Carlsmed (CARL) versus The Competition Financial Contrast - Defense World

Mar 07, 2026
pulisher
Mar 04, 2026

CARLSMED CEO Michael Cordonnier Sells Shares - TradingView

Mar 04, 2026
pulisher
Mar 03, 2026

Contrasting Carlsmed (CARL) & Its Rivals - Defense World

Mar 03, 2026
pulisher
Mar 02, 2026

CARL: Personalized spine surgery platform posts 86% annual growth and expands into cervical market - TradingView

Mar 02, 2026
pulisher
Mar 02, 2026

CARL: Personalized spine surgery platform drives rapid growth, clinical success, and strong reimbursement - TradingView

Mar 02, 2026
pulisher
Mar 02, 2026

Carlsmed (CARL) vs. Its Rivals Critical Survey - Defense World

Mar 02, 2026
pulisher
Mar 02, 2026

Brokerages Set Carlsmed, Inc. (NASDAQ:CARL) Target Price at $21.33 - Defense World

Mar 02, 2026
pulisher
Mar 01, 2026

Carlsmed (CARL) versus Its Peers Financial Contrast - Defense World

Mar 01, 2026
pulisher
Feb 28, 2026

Carlsmed (NASDAQ:CARL) Cut to “Strong Sell” at Zacks Research - Defense World

Feb 28, 2026
pulisher
Feb 27, 2026

Analysts Offer Insights on Healthcare Companies: Addus Homecare (ADUS), Wave Life Sciences (WVE) and Carlsmed, Inc. (CARL) - The Globe and Mail

Feb 27, 2026
pulisher
Feb 27, 2026

Carlsmed, Inc. (NASDAQ:CARL) Given Consensus Recommendation of "Hold" by Brokerages - MarketBeat

Feb 27, 2026
pulisher
Feb 27, 2026

Carlsmed (NASDAQ:CARL) Lowered to Strong Sell Rating by Zacks Research - MarketBeat

Feb 27, 2026
pulisher
Feb 27, 2026

Head to Head Survey: Carlsmed (CARL) versus Its Competitors - Defense World

Feb 27, 2026
pulisher
Feb 26, 2026

Carlsmed (CARL) Revenue Growth At 85.9% Tests Bearish Profitability Narratives - simplywall.st

Feb 26, 2026
pulisher
Feb 26, 2026

Carlsmed Q4 2025 revenue up 61% to USD 15.2M - Medical Buyer

Feb 26, 2026
pulisher
Feb 26, 2026

Carlsmed Q4 Earnings Call Highlights - MarketBeat

Feb 26, 2026
pulisher
Feb 25, 2026

Carlsmed, Inc. Reports Strong Q4 2025 Earnings and Growth Outlook - Intellectia AI

Feb 25, 2026
pulisher
Feb 25, 2026

Carlsmed Inc reports results for the quarter ended December 31Earnings Summary - TradingView

Feb 25, 2026
pulisher
Feb 25, 2026

Carlsmed Inc (NASDAQ:CARL) Reports Q4 Revenue Beat and Narrower-Than-Expected Loss - ChartMill

Feb 25, 2026
pulisher
Feb 25, 2026

Earnings call transcript: Carlsmed reports strong revenue, stock dips Q4 2025 - Investing.com

Feb 25, 2026

Finanzdaten der Carlsmed Inc-Aktie (CARL)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading

Carlsmed Inc-Aktie (CARL) Insiderhandel

Insiderhandel Beziehung Datum Transaktion Kosten #Aktien Wert ($) #Aktien Gesamt
Cordonnier Michael
CEO, President
Mar 02 '26
Option Exercise
0.34
197,855
66,281
1,554,501
Cordonnier Michael
CEO, President
Mar 02 '26
Sale
13.29
197,855
2,629,889
1,356,646
$23.12
price up icon 0.48%
$38.78
price up icon 2.51%
TXG TXG
$24.80
price up icon 5.17%
$22.25
price down icon 1.81%
$15.21
price up icon 5.70%
WAY WAY
$22.43
price up icon 1.22%
Kapitalisierung:     |  Volumen (24h):